Skip to main content

The Latest

  • Do not flush.
    CDC 'flush list' promotes human and environmental health risks
    Prescription drug diversion and abuse is a hot topic at FDA, inspiring blog posts, summit speeches, and co-promotion of DEA's annual prescription drug collection event. However, one piece of advice from FDA -- the "flush list" of...
  • National Take-Back Initiative
    National Prescription Drug Take-Back Day is April 26, 2014
    The Drug Enforcement Agency (DEA) has designated April 26, 2014, National Prescription Drug Take-Back Day. Part of the DEA Office of Diversion Control's National Take-Back Initiative, the day provides consumers an opportunity to turn over...
  • Cocaine tooth drops advertisement. Bears an 1885 date; no artist credit given.
    Big Pharma influence on academic medical centers exposed
    The potentially too cozy and extremely profitable relationship between big pharmaceutical companies (Big Pharma) and the board of directors of academic medical centers was detailed in an April 1, 2014, article in the Journal of the American...
  • Protesters for 'Stop Huntingdon Animal Cruelty' gather in front of the Bank of England on February 27, 2009, in London.
    Synthetic livers developed to end animal drug testing
    Dr. Mukund Chorghade, scientific officer of Empiriko Corporation and president of THINQ Pharma, presented a working model of a synthetic liver that is designed to eliminate animal testing for drugs and other products designed for human use at the...
  • CVS banning cigarettes
    The irony of a CVS cigarette ban
    A gigantic national pharmacy chain banning the sale of tobacco products because of their negative health effects is like a heroin dealer banning the sale of crack.Walk into any one of the 7,600 or so CVS drug stores in the US and it may actually...
  • Deutsche Post Tests Deliveries With Drones
    Mylan Pharmaceuticals receives FDA approval for a generic drug
    Yesterday Mylan Pharmaceuticals Inc. in Canonsburg, Pennsylvania announced the receipt of final approval from the U.S. Food and Drug Administration (FDA) for the launch for its Abbreviated New Drug Application (ANDA) of a generic drug which can be...
  • One in six children admitted to a hospital suffers an adverse drug reaction
    Getting sicker in the hospital: Adverse drug events and off-label medication
    As many as one child in every six experiences an adverse drug reaction (ADR) when admitted to a hospital, according to research published in the November 7, 2013, issue of BMC Medicine. Perhaps more disturbing, off-label or unlicensed (OLUL)...
  • The FDA is poised to withdraw its approval of 14 drugs whose manufacturers have failed to file required annual reports
    Say goodbye to drugs: FDA to withdraw 14 approvals
    The US Food and Drug Administration (FDA) has announced that it will withdraw its approval of 14 drugs if the drugs' sponsors do not file a written request for a hearing within 30 days of publication of the announcement in the Federal Register...
  • Barack Obama's FDA is considering relaxing premarket drug trial regulations, which may have been too lax under George W Bush's FDA
    How safe are your drugs?
    The Obama administration's FDA has proposed a relaxing of the rules for pre-approval drug trials, and new research published in the New England Journal of Medicine indicates that the rules may already be insufficient. According to an analysis...
  • Prescription slip and pill bottles
    Drug advertisement’s often misleading
    Six out of ten drug advertisements mislead the consumerFalse and misleading advertising for drugs can harm consumers and the healthcare system. Past research has shown that physician-targeted drug advertisements may be misleading. However, there...
  • The American Academy of Pediatrics urges nursing moms to check Toxnet
    Drugs while breastfeeding: AAP advocates caution
    The American Academy of Pediatrics (AAP) periodically publishes clinical reports, which contain guidance for clinicians whose patients fit into a particular category. Previously published clinical reports include The Prenatal Visit (for expectant...
  • Pharmaceutical Markets
    Dominating pharmaceutical emerging markets with data and analytics
    The pharmaceutical industry does not have it easy by any means—it costs between four and 11 billion dollars, on average, to develop a new drug, and it takes 12 years from discovery to market. Fewer than one in 10 drugs that start human...
  • Plan B
    Plan B decision needs follow through
    While women's rights groups applaud the Obama administration's decision to stop its pursuit of age restrictions for access to Plan B emergency contraception, they are less than optimistic when it comes to some glaring flaws in the...
  • multiple sclerosis drug maker Novartis sued by United States government
    Multiple sclerosis drug maker Novartis sued by United States government
    First things first, it needs to be reported the drugs listed in the suit against Novartis Pharmaceuticals Corp are Starlix (diabetes medication) and Lotrel and Valturna (hypertension medications), but Pamela Vaughn of Lima brings up a good...
  • Tanda
    Tanda: The new Zit zapper
    This handy zit zapper was recommended by fellow beauty expert Nicole Melton of Essence magazine. Let me say when this was the best fifty dollar investment I have ever made.Not only is this device FDA approved but it actually works.I have always...